Church & Dwight generates revenue through three reportable segments, with the Consumer Domestic segment contributing $4,732.3 million or 77.5% of FY2024 net sales, the Consumer International segment contributing $1,071.5 million or 17.5%, and the Specialty Products Division (SPD) contributing $303.3 million or 5.0%. The Consumer Domestic segment is further divided into household products and personal care products. Household products—including ARM & HAMMER laundry detergent, ARM & HAMMER cat litter, OxiClean stain fighters, Xtra laundry detergent, and ARM & HAMMER baking soda—accounted for approximately 42% of total corporate sales in FY2024. Personal care products—including Trojan condoms, Waterpik oral care devices, TheraBreath mouthwash, Hero Mighty Patch acne treatments, Batiste dry shampoo, Nair depilatories, First Response pregnancy tests, Spinbrush toothbrushes, Orajel oral analgesics, Zicam cold remedies, and the VITAFUSION/L'IL CRITTERS vitamin lines—accounted for approximately 35% of total corporate sales. The remaining 18% of sales comes from the Consumer International segment and SPD combined. The company's 14 power brands represent approximately 85% of total product sales, with ARM & HAMMER alone accounting for roughly 45% of domestic consumer product sales through its derivative trademarks spanning laundry detergent, cat litter, dental care, and baking soda. The remaining 13 power brands have all been added to the portfolio since 2001 through a series of strategic acquisitions. Revenue flows through a diversified channel mix: approximately 80% of total sales originate in the United States, with the balance split across Canada, Mexico, the UK, France, Germany, Australia, Brazil, and approximately 130 export markets. The company's e-commerce channel has grown from 1% of global sales in 2015 to 21.4% of total consumer sales in 2024, making Church & Dwight one of the online leaders in its peer group. The gross profit margin of 45.7% in FY2024—up from 44.1% in 2023—reflects 140 basis points of productivity program benefits, 100 basis points from favorable price/volume/mix, 50 basis points from a favorable tariff ruling that returned $40.1 million in cash refunds from the U.S. government for certain products imported from China, and 10 basis points from the Graphico acquisition, partially offset by 140 basis points of higher manufacturing costs including labor and commodities. Marketing expenses totaled $698.1 million in FY2024, representing 11.4% of net sales—up 50 basis points from 2023—as the company increased investment to support new product introductions including ARM & HAMMER Power Sheets laundry detergent, ARM & HAMMER Laundry Deep Clean Free & Clear, and Batiste Light dry shampoo. Selling, general, and administrative expenses were $927.8 million, or 15.2% of net sales, flat year-over-year as 60 basis points of growth investments in international division expansion, R&D, and IT were offset by 60 basis points of sales leverage. The operating margin of 13.3% in FY2024—down 470 basis points from 18.0% in 2023—was entirely attributable to the $357.1 million VMS impairment charge. Excluding this non-cash item, the adjusted operating margin would have been approximately 19.1%, demonstrating the underlying profitability of the core business model. The company's capital allocation prioritizes acquisitions, with $13.3 million in acquisition spending in FY2024 (primarily the Graphico acquisition and Passport food safety business sale), compared to $546.8 million in FY2022 and $475.0 million in FY2019. Free cash flow—defined as cash from operations minus capital expenditures—was $706.4 million in FY2024, with capital expenditures of $178.8 million primarily directed toward manufacturing capacity expansion and IT infrastructure. The company returned $277.0 million to shareholders through cash dividends in FY2024 and has maintained a dividend increase streak spanning more than 20 consecutive years. The business model's structural advantage lies in its asset-light acquisition framework: Church & Dwight targets brands with #1 or #2 market positions, typically paying 11-14x EBITDA, then integrates them into centralized manufacturing, distribution, and back-office functions. This approach has produced a consistent pattern of accretive deals—Waterpik (2017, $1 billion, 30% EBITDA margin), TheraBreath (2021, $580 million, 31% EBITDA margin), Hero Cosmetics (2022, $630 million, 40% EBITDA margin), and Touchland (2025, up to $880 million, 42% EBITDA margin)—each adding revenue streams with margins above the corporate average while requiring minimal incremental fixed-cost infrastructure.